The University of Queensland

HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia) (2007–2010)

Grant type:

Janssen-Cilag Pty Limited (Janssen-Cilag Australia)

Researchers:

• 

  Professor David Johnson

  NHMRC Leadership Fellow
  

  Centre for Health Services Research

  Faculty of Medicine

• 

  Professor Carmel Hawley

  ATH - Professor
  

  Princess Alexandra Hospital Southside Clinical Unit

  Faculty of Medicine

Funded by:

Janssen-Cilag Pty Limited (Janssen-Cilag Australia)